Modification To Burr Hole Valve And Shunt System
by Integra Neurosciences Implants S.A.
510(k) K040201
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK040201 | Date26 Feb 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JXG
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.5550
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Burr Hole Valve and Shunt System is a central nervous system component designed to shunt cerebrospinal fluid from the ventricles of the brain to an appropriate drainage site, such as the atrium of the heart or the peritoneal cavity. It functions as a flow-regulating valve system for the management of hydrocephalus.
This device is manufactured by Integra Neurosciences Implants S.A. and has received FDA 510k clearance. It is provided as a modification to the previously cleared Burr Hole Valve and Shunt System.
Other devices from Integra Neurosciences Implants S.A.
Questions
AI-generated answers, 22 Sep 2026
What is the primary function of the Burr Hole Valve and Shunt System?
This device is designed to manage hydrocephalus by acting as a flow-regulating valve system. It shunts cerebrospinal fluid from the brain's ventricles to an appropriate drainage site, such as the peritoneal cavity or the atrium of the heart.
Is this device a new product or a modification?
This device is provided as a modification to the previously cleared Burr Hole Valve and Shunt System. It has received FDA 510k clearance as a substantially equivalent component for central nervous system applications.
What is the regulatory status of this shunt system?
The device has received FDA 510k clearance under the neurology advisory committee. It is classified as a central nervous system shunt component, regulated under 21 CFR 882.5550.